Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous patient-controlled analgesia with oliceridine vs sufentanil after knee arthroscopy
ChiCTR2500112696Phase 4Not yet recruiting
- Sponsor
- Longhua District People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain and pain (2 arms), sponsored by Longhua District People's Hospital. Primary endpoints: Postoperative recovery quality at 24 hours, Perioperative adverse events and 2 more. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on ChiCTR2500112696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112696.